An evidence-based medicine strategy for achieving remission in bipolar disorder.
Controlled trials have demonstrated the efficacy of several classes of drugs for achieving acute response in bipolar mania and depression. For many years, clinical response has been the primary outcome in the majority of short-term efficacy studies. However, there is a growing consensus that the optimal goal in the long-term management of bipolar disorder is remission. The purpose of this article is to briefly summarize the clinical importance of remission in bipolar disorder and to review data on the effectiveness of available treatments for achieving and sustaining remission.
Beyer
John L
JL
Duke Mood and Anxiety Disorder Clinic, Duke University Medical Center, Durham, NC 27710, USA. beyer001@mc.duke.edu
D001714:Bipolar Disorder / Q000150:complications / Q000628:therapy*; D019317:Evidence-Based Medicine / Q000379:methods*; D006801:Humans; D010349:Patient Compliance; D012074:Remission Induction; D019966:Substance-Related Disorders / Q000150:complications / Q000517:prevention & control